Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06217146
Status:
TERMINATED
Last Update Posted:
2024-06-27
First Post:
2023-11-20
Brief Title:
A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia
Sponsor:
M H MediCane Ltd
Organization:
M H MediCane Ltd
Study Overview
Official Title:
A Two-part Study Part I an Open-label and Part II a Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of MediCanes Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia Including Probable Alzheimers Disease AD
Status:
TERMINATED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Part I Open-label was completed
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This double-blind placebo-controlled study is designed to assess the effectiveness of MediCanes medical cannabis oil extracted from MediCanes proprietary strain into GMP-grade olive oil as an add-on therapy to standard of care SoC in reducing agitation and disruptive behaviors in subjects with dementia including probable AD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None